for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

McKesson Corporation

MCK.N

Latest Trade

184.04USD

Change

0.89(+0.49%)

Volume

37,152

Today's Range

183.05

 - 

185.51

52 Week Range

112.75

 - 

187.17

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
183.15
Open
183.87
Volume
37,152
3M AVG Volume
22.73
Today's High
185.51
Today's Low
183.05
52 Week High
187.17
52 Week Low
112.75
Shares Out (MIL)
162.19
Market Cap (MIL)
29,706.02
Forward P/E
11.30
Dividend (Yield %)
0.91

Next Event

Q3 2021 Mckesson Corp Earnings Call

Latest Developments

More

Mckesson Corp Files Pricing Term Sheet For $500 Mln 0.900% Notes Due 2025

Mckesson Reports Q2 EPS Of $3.54

McKesson Q1 Adjusted Earnings Per Share $2.77

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About McKesson Corporation

McKesson Corporation is a healthcare supply chain management solution, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through three segments: United States Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions and Medical-Surgical Solutions. The United States Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare related products and provides pharmaceutical solutions to life sciences companies. European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers. Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers.

Industry

Biotechnology & Drugs

Contact Info

6555 State Highway 161

IRVING, TX

75039-2402

United States

+1.972.4464800

http://www.mckesson.com

Executive Leadership

Edward A. Mueller

Independent Chairman of the Board

Brian Scott Tyler

Chief Executive Officer, Director

Britt J. Vitalone

Chief Financial Officer, Executive Vice President

Tracy Faber

Chief Human Resource Officer, Executive Vice President

Nancy Flores

Executive Vice President, Chief Technology Officer, Chief Information Officer

Key Stats

2.00 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

208.4K

2019

214.3K

2020

231.1K

2021(E)

239.3K
EPS (USD)

2018

12.620

2019

13.570

2020

14.950

2021(E)

16.385
Price To Earnings (TTM)
14.23
Price To Sales (TTM)
0.13
Price To Book (MRQ)
5.06
Price To Cash Flow (TTM)
8.90
Total Debt To Equity (MRQ)
129.17
LT Debt To Equity (MRQ)
99.29
Return on Investment (TTM)
12.98
Return on Equity (TTM)
4.05

Latest News

Latest News

McKesson to replace some Moderna COVID-19 vaccines due to low temperature

McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said on Wednesday.

McKesson to replace some Moderna COVID-19 vaccines due to low temperature

McKesson Corp will replace some Moderna Inc COVID-19 vaccines in the United States after they arrived colder than the low end of the required temperature range, the company said in a statement on Wednesday. (Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)

Moderna COVID-19 vaccine begins rollout as U.S. races to broaden injection campaign

U.S. distribution of Moderna Inc's COVID-19 vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday, vastly widening the rollout started last week by Pfizer Inc.

Moderna, McKesson and U.S. Army general ready to roll out new COVID-19 vaccine

U.S. distribution of a second COVID-19 vaccine, from Moderna, is ready to start shipping to more than 3,800 sites this weekend, vastly widening the rollout begun last week with Pfizer, the drug company and distributor McKesson said.

Cardinal Health, AmerisourceBergen book billions in opioid settlement-related charges

Drug distributors AmerisourceBergen Corp and Cardinal Health Inc on Thursday reported $7.62 billion in new charges between them related to talks to resolve thousands of lawsuits alleging they helped fuel the U.S. opioid epidemic.

McKesson says states seek $21 billion from drug distributors in opioid settlement

McKesson Corp <MCK.N> on Tuesday said it and two other major U.S. drug distributors could be expected to pay up to $21 billion under a new proposal to resolve thousands of lawsuits alleging they helped fuel the U.S. opioid crisis.

McKesson wins dismissal of whistleblower suit over opioid diversion

Drug distributor McKesson Corp has won dismissal of a whistleblower lawsuit by two former employees accusing the company of doing an inadequate job of protecting its product, addictive opioids, from theft.

Trump Administration picks McKesson for coronavirus vaccine distribution

The U.S. Department of Health and Human Services (HHS) said on Friday that McKesson Corp <MCK.N> would be the central distributor for future coronavirus vaccines, sending the U.S. drug distributor's shares up more than 3%.

BRIEF-Trump Administration Collaborates With McKesson For COVID-19 Vaccine Distribution

* HHS - TRUMP ADMINISTRATION COLLABORATES WITH MCKESSON FOR COVID-19 VACCINE DISTRIBUTION

Trump Administration picks McKesson for coronavirus vaccine distribution

The U.S. Department of Health and Human Services said on Friday that McKesson Corp would be the central distributor for future coronavirus vaccines.

BRIEF-McKesson Says Co Realigned Organizational Structure To Better Serve Customers, Patients

* MCKESSON REALIGNS ORGANIZATIONAL STRUCTURE TO BETTER SERVE CUSTOMERS AND PATIENTS WHILE OPTIMIZING GROWTH

BRIEF-Mckesson Says CEO's FY 2020 Total Compensation Was $15.4 Mln Vs $12.6 Mln In FY 2019 - SEC Filing

* MCKESSON CORP SAYS CEO BRIAN S. TYLER'S FY 2020 TOTAL COMPENSATION WAS $15.4 MILLION VERSUS $12.6 MILLION IN FY 2019 - SEC FILING

BRIEF-McKesson Appoints Tom Rodgers To Executive Vice President

* MCKESSON APPOINTS TOM RODGERS TO EXECUTIVE VICE PRESIDENT & CHIEF STRATEGY AND BUSINESS DEVELOPMENT OFFICER Source text for Eikon: Further company coverage:

BRIEF-Mckesson Reports Q4 Adjusted EPS Of $4.27

* MCKESSON REPORTS FISCAL 2020 FOURTH-QUARTER AND FULL-YEAR RESULTS

BRIEF-Mckesson Declares Quarterly Dividend April 29, 2020

* SETS REGULAR QUARTERLY DIVIDEND OF $0.41PER SHARE Source text for Eikon: Further company coverage:

BRIEF-Mckesson Announces Bansi Nagji To Step Down As Executive Vice President, Chief Strategy And Business Development Officer

* MCKESSON ANNOUNCES BANSI NAGJI TO STEP DOWN AS EXECUTIVE VICE PRESIDENT, CHIEF STRATEGY AND BUSINESS DEVELOPMENT OFFICER Source text for Eikon: Further company coverage:

BRIEF-Mckesson Updates Fiscal 2020 Guidance Following Completion Of Change Healthcare Split-Off

* MCKESSON UPDATES FISCAL 2020 GUIDANCE FOLLOWING COMPLETION OF CHANGE HEALTHCARE SPLIT-OFF

BRIEF-Mckesson Sets Final Exchange Ratio Of 11.4086 For Exchange Offer

* MCKESSON SETS FINAL EXCHANGE RATIO OF 11.4086 FOR EXCHANGE OFFER

BRIEF-McKesson, Opioid Distributors Propose $1 Billion Legal Fee Fund - Bloomberg News

* MCKESSON, OPIOID DISTRIBUTORS PROPOSE $1 BILLION LEGAL FEE FUND - BLOOMBERG NEWS Source text - https://bloom.bg/32dcGZY Further company coverage:

BRIEF-Mckesson Launches Exchange Offer To Split-Off Its Interest In Change Healthcare

* MCKESSON LAUNCHES EXCHANGE OFFER TO SPLIT-OFF ITS INTEREST IN CHANGE HEALTHCARE

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up